NORPACT-1: implications for future trials

Lancet Gastroenterol Hepatol. 2024 May;9(5):408. doi: 10.1016/S2468-1253(24)00054-2.

Authors

Rebecca A Snyder¹, Matthew H G Katz²

Affiliations

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA.
² Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA. Electronic address: mhgkatz@mdanderson.org.

PMID: 38604195
DOI: 10.1016/S2468-1253(24)00054-2

No abstract available

Publication types

Letter